The Committee Expects Delivery Assurance. Your Team Does Financial Controls.

The assurance gap sits between what the committee expects and what IA can credibly deliver

The audit committee increasingly asks Internal Audit for assurance on major program delivery. This is a reasonable request — material capital programs carry material risk, and the committee expects its third line of defence to provide independent assurance across the portfolio. The difficulty is that program delivery assurance is a specialist domain. IA’s core competency is financial controls, compliance, and operational risk. Assuring whether a $10 million transformation program has the control health, business readiness, and stakeholder alignment to succeed at the next funding gate requires subject-matter expertise that most IA functions were not built to provide.

The typical response is to commission Big-4 assurance. It is credible, thorough, and runs $50,000 to $80,000 per engagement with a four-to-eight-week lead time. At that cost and cadence, it cannot be sustained at every stage gate across every material program. You commission it selectively on the highest-profile investments. The rest pass through with PMO reporting — which is internally generated, not independent, and does not meet the third-line standard the committee expects.

Panel constraints compound the problem. Where organisations require assurance providers from an approved panel, David controls the commissioning but not the execution. Panel providers define their own scope, select their own methodology, and resource the engagement from their bench. There is no mechanism to enforce quality standards, prevent scope narrowing, or require named practitioners. The result is assurance quality variability across engagements that the committee treats as equivalent.

Generic maturity frameworks do not close the gap either. They measure process adherence — whether templates exist, whether governance meetings are held — not control adequacy or business readiness. They do not produce a decision-grade output the committee can act on. The committee receives a process compliance assessment when what it needs is an independent answer to a specific question: should we release the next tranche?

Your instrument, your audit plan, your findings

ProjectPhD is a specialist stage-gate diagnostic designed to be commissioned by Internal Audit as a recognised control within the annual audit plan. It sits alongside financial audits and compliance reviews — not as a replacement for audit, but as a specialist instrument for a domain that requires specialist assessment. The scope boundaries are explicit: ProjectPhD performs stage-gate control diagnostics; Internal Audit performs audit. Different mandate, different output, additive rather than competitive. You do not need to become a delivery assurance specialist. You commission a specialist instrument and apply your audit judgement to the findings.

Within 48 hours, you receive a Board Assurance Report that benchmarks the program against a matched peer cohort — programs of comparable size, sector, category, and complexity — and produces conditions-to-proceed with a decision-grade recommendation: proceed, step-up discipline, or commission full assurance. The methodology is standardised and versioned. Each report records the methodology version applied. You can cite it in audit findings as a recognised, evidence-based framework — not your team’s assessment, not a personal opinion, but an independently scored diagnostic with transparent methodology provenance. When the committee asks how the finding was derived, the answer is documented.

The evidence base is corroborated through multi-respondent attestation across roles, with the Alignment Index surfacing where stakeholder views diverge. Independence guardrails are published and standing: standardised scoring not adjusted to client expectations, no contingent fees, disclosed conflicts of interest, and second-review sign-off at higher tiers. These controls are designed to withstand the independence scrutiny that Internal Audit applies to any instrument it recommends. Where a stronger evidence base is required, the Evidence Review tier provides uploads-based artefact assessment with redaction, retention controls, and data residency options.

When the diagnostic recommends full assurance and panel restrictions apply, the Panel-RFP Pack provides the mechanism that currently does not exist: a controlled scope document specifying methodology requirements, named-resourcing criteria, deliverable standards, and evaluation criteria — issued to up to three panel providers. This gives you control over assurance quality under panel rules, regardless of which provider wins the engagement. No other instrument occupies this position.

20-YEAR EMPIRICAL RECORD

Built on 20 years of specialist delivery assurance practice

The benchmark dataset draws on 2,000+ diagnostics conducted over 20 years of program assurance practice, with roughly a quarter in ERP and core systems and a fifth in regulatory change. Outcome data from 1,200 programs is coded against whether sponsors judged the program delivered to expectations and achieved its intended business outcomes. Statistical regression is applied to calculate correlations and confidence levels. Where cohort matching is thin, confidence intervals are widened and disclosed. Every recommended condition is drawn from the ProjectPhD Recommendations Library — interventions grounded in what governance forums actually needed at the funding gate across comparable programs.

The diagnostic explicitly assesses business readiness and adoption risk alongside delivery controls — recognising that programs which complete their technical deliverables but where the organisation is not prepared to adopt the outcome represent a systemic failure pattern that output-tracking frameworks miss. The methodology does not stretch beyond what the evidence supports. It is your documented due diligence.